Skip to main content
Year archive

Kuros Biosciences Ltd. — 2009 filings

All 9 regulatory filings released by Kuros Biosciences Ltd. (KURN) in 2009, sourced directly from the official regulator.

9 Filings
2009 Period
2009 filings (9)
Filing Released Lang
Cytos Biotechnology updates on the development of the hypertension vaccine CYT006-AngQb
Regulatory Filings
2009-11-10 English
Cytos Biotechnology AG Third Quarter Report 2009
Earnings Release 9M 2009
2009-10-22 English
Interim analysis of an ongoing phase II study with nicotine vaccine shows primary endpoint not achieved
Legal Proceedings Report
2009-10-15 English
Cytos Biotechnology AG: CYT003-QbG10 monotherapy for the treatment of allergic rhinoconjunctivitis is safe and efficacious in phase IIb study
Earnings Release Q3 2009
2009-07-31 English
Cytos Biotechnology Ltd Second Quarter Report 2009
Report Publication Announcement
2009-07-23 English
Cytos Biotechnology reports biochemical findings from phase IIa study with hypertension vaccine CYT006-AngQb
Regulatory Filings
2009-06-24 English
Cytos Biotechnology Ltd: Initiation of combined phase I/IIa study with a novel anti-interleukin-1 beta vaccine in patients with type II diabetes mellitus
Legal Proceedings Report
2009-06-11 English
Cytos Biotechnology AG: First Quarter Report 2009
Report Publication Announcement Q1 2009
2009-04-22 English
Cytos Biotechnology Ltd: Start of phase IIa study with CYT003-QbG10 monotherapy in patients with allergic asthma bronchiale
Legal Proceedings Report
2009-04-21 English